Vicore Pharma Data Update: Presenting the positive interim data from AIR, a phase 2 trial in idiopathic pulmonary fibrosis (IPF)
| DATE: | November 4, 2022 |
|---|---|
| TIME: | 8:00 AM EDT |
| LOCATION: | Virtual |
About The Event
Vicore Pharma hosts a program update presenting the new positive interim data from AIR, a phase 2 trial in idiopathic pulmonary fibrosis (IPF). The data will be presented by Professor Toby Maher, MBBS, MSc, PhD (Keck school of medicine University of Southern California, Los Angeles).
A live Q&A session will follow the formal presentation.